Latest updates
- In the press Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema
- Insights Exonate at Biotrinity 2022
- Company news Exonate at Biotrinity 2021
- Insights Exonate announces involvement in exciting STEM outreach project.
- In the press Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
- Awards Exonate finalists for OBN’s 2020 Most Impactful UK Deal Award